J. Z. Sanborn, Ph.D.
Affiliations: | Biomolecular Engineering and Bioinformatics | University of California, Santa Cruz, Santa Cruz, CA, United States |
Google:
"J. Sanborn"Parents
Sign in to add mentor| David Henry Haussler | grad student | 2012 | UC Santa Cruz | |
| (Tumor versus matched-normal sequencing analysis and data integration.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Reimann H, Nguyen A, Sanborn JZ, et al. (2021) Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy. Journal For Immunotherapy of Cancer. 9 |
| Denkert C, Untch M, Benz S, et al. (2021) Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 32: 500-511 |
| Newton Y, Sedgewick AJ, Cisneros L, et al. (2020) Large scale, robust, and accurate whole transcriptome profiling from clinical formalin-fixed paraffin-embedded samples. Scientific Reports. 10: 17597 |
| Kang T, Yau C, Wong CK, et al. (2020) A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population. Breast Cancer Research : Bcr. 22: 81 |
| Adashek JJ, Kato S, Parulkar R, et al. (2020) Transcriptomic silencing as a potential mechanism of treatment resistance. Jci Insight. 5 |
| Heskett MB, Sanborn JZ, Boniface C, et al. (2020) Multiregion exome sequencing of ovarian immature teratomas reveals 2N near-diploid genomes, paucity of somatic mutations, and extensive allelic imbalances shared across mature, immature, and disseminated components. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc |
| Lee KL, Benz SC, Hicks KC, et al. (2019) Efficient tumor clearance and diversified immunity through neoepitope vaccines and combinatorial immunotherapy. Cancer Immunology Research |
| Newton Y, Golovato J, Tan IB, et al. (2019) Genomic and immune infiltration differences between MSI and MSS GI tumors. Journal of Clinical Oncology. 37: 528-528 |
| North JP, Golovato J, Vaske CJ, et al. (2018) Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma. Nature Communications. 9: 1894 |
| Rabizadeh S, Garner C, Sanborn JZ, et al. (2018) Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer. Oncotarget. 9: 19223-19232 |